Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III withdrawal study of colestilan versus placebo after open-label titration with colestilan or sevelamer in dialysis patients with hyperphosphataemia
2006-003323-37Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of colestilan in hyperphosphatemia (3 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Started Nov 2006; status: completed.
02
Drugs
colestilan
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2006-003323-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003323-37.